Rock Springs Capital Management LP's Form 4 filing
Theseus Pharmaceuticals, Inc. (THRX) · filed Oct 14, 2021
- Accession no.
- 0000899243-21-040255
- Filed
- Oct 14, 2021, 5:00 PM ET
- Trade date
- Oct 12, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $4.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rock Springs Capital Management LPCIK 0001595725 | 10% Owner |
| Rock Springs Capital Master Fund LPCIK 0001735393 | 10% Owner |
| Rock Springs Capital LLCCIK 0001735397 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2021 | Common Stock | CConversionAcquired | +349,320 | –F2 | – | 349,320 | Indirect | |
| Oct 12, 2021 | Common Stock | CConversionAcquired | +87,329 | –F2 | – | 87,329 | Indirect | |
| Oct 12, 2021 | Common Stock | PPurchaseAcquired | +250,000 | $16.00 | +$4,000,000 | 599,320 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The reported security converted into the issuer's Common Stock on a one-for-one basis automatically immediately prior to the closing of the issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.